Skip to Content
Merck
CN

SAB3701437

Monoclonal Anti-HSP27 antibody produced in mouse

clone G3.1, purified immunoglobulin

Synonym(s):

Anti-Heat shock 27 kDa protein antibody, Anti-Heat shock cognate protein 71-kDa antibody, Anti-HspB1 antibody, Anti-SRP27 antibody, Anti-Stress-responsive protein 27 antibody

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
G3.1, monoclonal
Application:
ELISA, WB
Citations:
1

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

mouse

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

G3.1, monoclonal

form

buffered aqueous solution

species reactivity

human

technique(s)

ELISA: suitable, western blot: suitable

isotype

IgG1κ

UniProt accession no.

P04792

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Quality Level

100

Gene Information

human ... HSPB1(3315)

Immunogen

Prokaryotic recombinant protein corresponding to the full length human hsp27 protein.

Biochem/physiol Actions

This protein A purified mouse monoclonal antibody reacts specifically with HSP27 in human tissues and cell lines.  MCF-7 cells are recommended as a positive control.  Cross reactivity with hsp27 from other mammalian sources is likely.  No cross reactivity occurs with HSP70, HSP90 or HSP104.

Features and Benefits

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

Physical form

Supplied in 0.02 M Potassium Phosphate, 0.5 M Sodium Chloride, pH 7.2 with 0.01% (w/v) Sodium Azide

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
9835

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Jihad Karam et al.
Molecular and clinical oncology, 7(5), 808-814 (2017-11-29)
Late detection and lack of standard treatment strategies in larynx cancer patients result in high levels of mortality and poor prognosis. Prognostic stratification of larynx cancer patients based on molecular prognostic tumor biomarkers may lead to more efficient clinical management.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service